Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure

被引:10
|
作者
Qiu, Liyuan [1 ,2 ]
Wang, Jian [3 ]
Wen, Xinyu [4 ]
Wang, Haibin [1 ,2 ]
Wang, Yan [1 ,2 ]
Lin, Qiuxia [1 ,2 ]
Du, Zhiyan [1 ,2 ]
Duan, Cuimi [1 ,2 ]
Wang, Chunren [3 ]
Wang, Changyong [1 ,2 ]
机构
[1] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing 100850, Peoples R China
[2] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100850, Peoples R China
[3] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China
关键词
Co-microencapsulated; FHF; Hepatocyte; HUVEC; Transplantation; MARROW STEM-CELLS; LIVER-FAILURE; INTRASPLENIC TRANSPLANTATION; PORCINE HEPATOCYTES; ENDOTHELIAL-CELLS; IMPROVED SURVIVAL; RATS; ISLETS; COENCAPSULATION; HEPATECTOMY;
D O I
10.5301/ijao.5000092
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: Microencapsulated hepatocytes might solve immunological rejection, broadening a new perspective for the treatment of fulminant hepatic failure (FHF). However, the transplantation of microcapsulated hepatocytes is limited by low cell viability. Nevertheless, the.co-microencapsulation of hepatocytes and human umbilical vein endothelial cells (HUVECs) may make the treatment of FHF more promising. Methods: We prepared the microcapsules using the high-voltage electrostatic droplet spray method, transplanted the empty microcapsules, isolated hepatocytes, microcapsulated hepatocytes, and co-microencapsulated hepatocytes and HUVEC intraperitoneally into rat models of FHF induced by D-aminogalactose (D-gal). After 1, 3, and 7 days, and 2, 3, and 4 weeks posttransplantation, we calculated the mortality and assessed alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) levels in the serum of the model; evaluated the integrality and recovery of microcapsules; and stained with hematoxylin and eosin (H&E) the recovered microcapsules as well as the liver of the FHF rats. Results: Hepatocyte-specific functions, including the levels of ALT, AST and ALB in the serum of the co-microencapsulation group, were significantly better than those in the other groups (p < 0.05) from 2 to 4 weeks after transplantation. Moreover, cotransplantation of the microencapsulated hepatocytes and HUVECs decreased the mortality rate of the FHF rats. The recovered microcapsules were intact, and recovery was up to 90%. H&E staining showed that the microencapsulated cells were still alive, and the liver tissues had started to recover after 4 weeks posttransplantation. Conclusion: The microcapsules have good biocompatibility and immunoprotection to protect the hepatocytes from immunological rejection. Cotransplantation of the microencapsulated hepatocytes and HUVECs could decrease mortality rates and improve liver function in FHF
引用
收藏
页码:458 / 465
页数:8
相关论文
共 46 条
  • [21] Fulminant hepatic failure after simultaneous kidney-pancreas transplantation: a case report
    Moss, Jimmy L.
    Brown, Benjamin W.
    Pai, Sher-Lu
    Torp, Klaus D.
    Aniskevich, Stephen
    REVISTA BRASILEIRA DE ANESTESIOLOGIA, 2018, 68 (05): : 535 - 538
  • [22] Use of extracorporeal liver assist device and auxiliary liver transplantation in fulminant hepatic failure
    McCarthy, M
    Ellis, AJ
    Wendon, JA
    Heaton, N
    Rela, M
    BuxtonThomas, M
    Hughes, RD
    Portmann, BC
    Williams, R
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (04) : 407 - 412
  • [23] ATRACURIUM INFUSIONS IN PATIENTS WITH FULMINANT HEPATIC-FAILURE AWAITING LIVER-TRANSPLANTATION
    BION, JF
    BOWDEN, MI
    CHOW, B
    HONISBERGER, L
    WEATHERLEY, BC
    INTENSIVE CARE MEDICINE, 1993, 19 : S94 - S98
  • [24] An Effective Treatment of Fulminant Hepatic Failure: A Single-Center Retrospective Study
    Duan, Xin
    Yan, Liting
    Zhang, Wei
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (11) : 859 - 864
  • [25] FLUMAZENIL IN THE TREATMENT OF HEPATIC-ENCEPHALOPATHY IN CHILDREN WITH FULMINANT LIVER-FAILURE
    DEVICTOR, D
    TAHIRI, C
    LANCHIER, C
    NAVELET, Y
    DURAND, P
    ROUSSET, A
    INTENSIVE CARE MEDICINE, 1995, 21 (03) : 253 - 256
  • [27] Aggressive Treatment of Life-Threatening Hypophosphatemia During Recovery From Fulminant Hepatic Failure: A Case Report
    Bissell, Brittany D.
    Davis, Jason E.
    Flannery, Alexander H.
    Adkins, David A.
    Bastin, Melissa L. Thompson
    JOURNAL OF INTENSIVE CARE MEDICINE, 2018, 33 (06) : 375 - 379
  • [28] Return of the Metabolic Trajectory to the Original Area after Human Bone Marrow Mesenchymal Stem Cell Transplantation for the Treatment of Fulminant Hepatic Failure
    Li, Jun
    Xin, Jiaojiao
    Hao, Shaorui
    Zhang, Liyuan
    Jiang, Longyan
    Chen, Deying
    Xie, Qing
    Xu, Wei
    Cao, Hongcui
    Li, Lanjuan
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (06) : 3414 - 3422
  • [29] N-acetylcysteine for the treatment of clove oil-induced fulminant hepatic failure
    Eisen, JS
    Koren, G
    Juurlink, DN
    Ng, VL
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2004, 42 (01): : 89 - 92
  • [30] Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure:A 20-year experience
    Olivier Detry
    Arnaud De Roover
    Carla Coimbra
    Jean Delwaide
    Marie-France Hans
    Marie Hélène Delbouille
    Joseé Monard
    Jean Joris
    Pierre Damas
    Jacques Belache
    Michel Meurisse
    Pierre Honoré
    World Journal of Gastroenterology, 2007, (09) : 1427 - 1430